Meet the team

Cell Medica has a world-class team with experienced senior management and a research-leading scientific advisory board.

Clinical trials

We are currently running two clinical trials to demonstrate the therapeutic benefit of Cytovir CMV for the prevention of infections in bone marrow (haematopoietic stem cell) transplant patients.

More information

Anti-cancer therapy

Cytorex EBV: a revolutionary approach to treating cancer associated with the oncogenic Epstein Barr virus.

More information

Paediatric study

Cytovir ADV, for the treatment of life-threatening adenovirus infections in children, will be tested in a clinical trial planned with the Institute of Child Health/Great Ormond Street Hospital.

More information

About Cell Medica

Cell Medica develops, manufactures and markets patient-specific cellular immunotherapy products comprised of antigen-specific T cells for the treatment of infectious disease and cancer.

Cell Medica and UCL Institute of Child Health Receive Grant Funding from UK Technology Strategy Board for Paediatric Cell Therapy Study Published: 10/01/2012 in Press releases
Cell Medica secures further Wellcome Trust funding for completion of the CMV~IMPACT study. Published: 23/09/2011 in Press releases
Cell Medica announces first patient treated in Cytomegalovirus~ACE/ASPECT Clinical Trial Published: 10/02/2011 in Press releases

More news

Meet the team

Clinical trials

Anti-cancer therapy

Paediatric study

About Cell Medica

Press releases